Journal of Clinical Pathology 2009;62:579-583
REVIEWS
Intraductal carcinoma of the prostate: a distinct histopathological entity with important prognostic implications
Department of Pathology, University Health Network, Toronto, Ontario, Canada
Dr A J Evans, University Health Network, Toronto General Hospital, 200 Elizabeth Street, Toronto, Ontario, M5G 2C6, Canada; andrew.evans{at}uhn.on.ca
Intraductal carcinoma of the prostate (IDCP) has been described as a lesion associated with poor prognostic features in prostate cancer. Its recognition and reporting in prostate specimens, particularly in needle biopsies, is critical as it carries significant implications for patient management. Recent histological definitions have been proposed to assist in the recognition of IDCP and to help distinguish it from lesions with similar appearance, but different clinical behaviour. In this review, a historical overview of the description of IDCP will be presented followed by a summary of the current histological diagnostic criteria and the recommendations for management and reporting of IDCP.
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
